• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风病诊所中的治疗监测与药剂师干预

Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic.

作者信息

Piscitelli S C, Occhipinti D J, Danziger L H, Hill C, West D P, Fischer J H

机构信息

Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago 60612.

出版信息

Ann Pharmacother. 1993 Dec;27(12):1526-31. doi: 10.1177/106002809302701220.

DOI:10.1177/106002809302701220
PMID:8305789
Abstract

OBJECTIVE

To describe the role of the clinical pharmacist in a Hansen's disease (HD, leprosy) clinic and to describe the development, validation, and operation of a dapsone compliance monitoring program.

RATIONALE

HD remains a major, worldwide healthcare problem. Dapsone is the drug of choice for treatment of HD; however, high rates of noncompliance with this agent have been reported by many treatment centers. The assessment of compliance in HD patients is important to help distinguish between treatment failure secondary to noncompliance or to the development of resistance.

SETTING

In the US, the Chicago Regional Hansen's Disease Center at the University of Illinois at Chicago is one of ten centers that provide comprehensive care to patients diagnosed with this condition. This article reviews the clinical pharmacy services and dapsone compliance program in the clinic encompassing the years 1983-93.

RESULTS

The clinical pharmacist provides a variety of clinical services in the clinic as well as coordinating the clinical research program. A pharmacist-generated dapsone compliance program led to improvement in compliance rates and clinical outcome. This improvement in compliance has been sustained over an extended period of time.

CONCLUSIONS

The clinical pharmacy services performed in the HD clinic provide a model for pharmacy involvement in other chronic disease states. The dapsone compliance program has been successful in improving patient care and obtaining reimbursement for clinical pharmacy services.

摘要

目的

描述临床药师在麻风病诊所中的作用,并描述氨苯砜依从性监测项目的开发、验证和运行情况。

理论依据

麻风病仍是一个全球性的重大医疗问题。氨苯砜是治疗麻风病的首选药物;然而,许多治疗中心报告该药物的不依从率很高。评估麻风病患者的依从性对于区分因不依从或耐药性发展导致的治疗失败很重要。

背景

在美国,位于芝加哥伊利诺伊大学的芝加哥地区麻风病中心是为诊断为此病的患者提供全面护理的十个中心之一。本文回顾了1983年至1993年该诊所的临床药学服务和氨苯砜依从性项目。

结果

临床药师在诊所提供各种临床服务,并协调临床研究项目。由药师制定的氨苯砜依从性项目提高了依从率和临床疗效。这种依从性的改善在很长一段时间内得以维持。

结论

麻风病诊所开展的临床药学服务为药学参与其他慢性病治疗提供了一个模式。氨苯砜依从性项目成功改善了患者护理,并为临床药学服务获得了报销。

相似文献

1
Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic.麻风病诊所中的治疗监测与药剂师干预
Ann Pharmacother. 1993 Dec;27(12):1526-31. doi: 10.1177/106002809302701220.
2
Evaluation of a continual compliance monitoring program for dapsone in an outpatient Hansen's disease clinic.
Int J Lepr Other Mycobact Dis. 1986 Dec;54(4):517-24.
3
Treatment of Hansen's disease.麻风病的治疗。
Am Fam Physician. 2002 Apr 1;65(7):1280, 1282; author reply 1282.
4
Treatment of Hansen's disease.麻风病的治疗。
Cutis. 1976 Jul;18(1):62-5.
5
Treating Hansen's disease in developing countries.在发展中国家治疗汉森病。
West J Med. 1994 Mar;160(3):278; author reply 279-80.
6
Leprosy (Hansen's disease).麻风病(汉森氏病)。
Otolaryngol Clin North Am. 1982 Aug;15(3):597-611.
7
Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.在瘤型麻风的初始治疗中,每月一次服用利福平(1200毫克),同时每日服用氨苯砜(100毫克)和氯法齐明(100毫克)。
Indian J Lepr. 1984 Jan-Mar;56(1):63-70.
8
Impact of multidrug therapy on the treatment and control of leprosy.
Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):458-78.
9
Effectiveness of a dapsone compliance program in leprosy.氨苯砜依从性方案在麻风病治疗中的有效性
Int J Dermatol. 1993 Mar;32(3):206-9. doi: 10.1111/j.1365-4362.1993.tb02797.x.
10
Multi-drug therapy in bacilliferous leprosy--two years experience.含菌型麻风病的多药联合治疗——两年经验
Indian J Lepr. 1985 Jul-Sep;57(3):483-90.